For instance, in acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and classical Hodgkin’s lymphoma (cHL), Gal-3 overexpression is associated with poor survival and prognosis [124,125,126]. This evidence concerns the gene LGALS3 and B-cell chronic lymphocytic leukemia.